Importer of Controlled Substances; Notice of Registration, 10076-10077 [E9-4945]
Download as PDF
<![CDATA[
10076
Federal Register / Vol. 74, No. 44 / Monday, March 9, 2009 / Notices
practitioner [be] licensed under the laws
of this State’’).
As I have previously explained, an
entity which voluntarily engages in
commerce by shipping controlled
substances to persons located in other
States is properly charged with
knowledge of the laws regarding both
the practice of medicine and pharmacy
in those States. United, 72 FR at 50408.
In short, given that Dr. Aghaegbuna was
licensed to practice medicine in
Virginia, and yet was prescribing to
persons who did not reside in that State
and who frequently lived hundreds of—
and in many instances more than a
thousand—miles away,8 Respondent
had ample reason to know that the
prescriptions were unlawful under both
the CSA and the laws of numerous
States. See id. at 50409.9
As the forgoing demonstrates,
Respondent knowingly violated Federal
law in dispensing thousands of
prescriptions which lacked a
legitimated purpose and were issued by
practitioners acting outside of the usual
course of professional practice. 21 CFR
1306.04(a). Respondent’s experience in
dispensing controlled substances is thus
characterized by its repeated and
flagrant violations of both the CSA and
State laws; the scope of its illegal
dispensings clearly establish that its
continued registration was ‘‘inconsistent
with the public interest,’’ and posed ‘‘an
imminent danger to the public health or
safety’’ which warranted the immediate
suspension of its registration.10 21
U.S.C. 824(a) & (d).
Order
Pursuant to the authority vested in me
by 21 U.S.C. 824, as well as 28 CFR
0.100(b) & 0.104, I affirm my order
which immediately suspended the nowexpired DEA Certificate of Registration,
BM3972747, issued to Meetinghouse
Community Pharmacy, Inc. This order is
effective immediately.
Dated: February 26, 2009.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E9–4909 Filed 3–6–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated November 26, 2008,
and published in the Federal Register
on December 5, 2008, (73 FR 74194),
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Schedule
dwashington3 on PROD1PC60 with NOTICES
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
Fenethylline (1503) ......................................................................................................................................................................................
Gamma hydroxybutyric acid (2010) ............................................................................................................................................................
Ibogaine (7260) ...........................................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine(7348) ................................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
Alpha-methyltryptamine (7432) ...................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
N-Benzylpiperazine (7493) ..........................................................................................................................................................................
Etorphine (except HCl) (9056) ....................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Morphine-N-oxide (9307) .............................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Pholcodine (9314) .......................................................................................................................................................................................
Dextromoramide (9613) ...............................................................................................................................................................................
Dipipanone (9622) .......................................................................................................................................................................................
Trimeperidine (9646) ...................................................................................................................................................................................
8 In particular, I rely on the prescriptions Dr.
Aghaegbuna issued to residents of California,
Hawaii, and Texas. In preparing this Order, I have
visited the Web sites of the medical licensing
authorities of these States and verified that Dr.
Aghaegbuna was not licensed by them.
I have also visited the Web sites of the respective
State authorities of Illinois, Michigan, and New
Hampshire, and determined that Dr. Burr was not
licensed in these States. Respondent nonetheless
VerDate Nov<24>2008
15:28 Mar 06, 2009
Jkt 217001
dispensed prescriptions issued by Dr. Burr for
residents of these States in violation of state and
Federal laws.
9 Respondent also had ample reason to know that
prescriptions were unlawful because he knew that
the prescribers were not physically examining the
patients. As Mr. Ihenacho wrote in a March 8, 2007
e-mail, ‘‘I do not feel very comfortable at all feeling
[sic] medications where I know that there is really
no doctor/patient interaction.’’ Indeed, under
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
numerous State medical practice standards, with
only limited exceptions, a physician must take a
medical history and physically examine a patient in
order to properly diagnose the patient and
recommend treatment options including prescribing
a drug. See, e.g., N.J. Admin. Code 13:35–7.1A(a);
S.C. Code Regs. 81–28.
10 To make clear, I would have revoked
Respondent’s registration had it not expired prior
to the issuance of this Order.
E:\FR\FM\09MRN1.SGM
09MRN1
10077
Federal Register / Vol. 74, No. 44 / Monday, March 9, 2009 / Notices
Drug
Schedule
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Methylphenidate (1724) ...............................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Pentobarbital (2270) ....................................................................................................................................................................................
Secobarbital (2315) .....................................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Phenylacetone (8501) .................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Benzoylecgonine (9180) ..............................................................................................................................................................................
Ethylmorphine (9190) ..................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) (9273) ..............................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Oripavine (9330) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Oxymorphone (9652) ...................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
dwashington3 on PROD1PC60 with NOTICES
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Cerilliant Corporation to import the
basic classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Cerilliant Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: March 4, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–4945 Filed 3–6–09; 8:45 am]
BILLING CODE 4410–09–P
VerDate Nov<24>2008
15:28 Mar 06, 2009
Jkt 217001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 06–78]
Steven M. Abbadessa, D.O.; Grant of
Restricted Registration
On August 7, 2006, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Steven M. Abbadessa,
D.O. (Respondent), of St. Louis,
Missouri. The Show Cause Order
proposed the denial of Respondent’s
pending application for a DEA
Certificate of Registration as a
practitioner, on the ground that his
‘‘registration would be inconsistent with
the public interest.’’ Id. at 1 (citing 21
U.S.C. 823(f)).
The Show Cause Order specifically
alleged that ‘‘[o]n or about January 1981,
[Respondent] illegally possessed and
distributed * * * cocaine in violation of
21 U.S.C. 841(a)(1),’’ that Respondent
was subsequently charged and arrested,
and that he had admitted to agents that
he had been involved ‘‘in the illegal
distribution of cocaine, a schedule II
controlled substance,’’ but that ‘‘no
further prosecution was undertaken’’
because he cooperated with authorities.
Id.
The Show Cause Order next alleged
that on December 4, 2001, Respondent
was arrested by local police at a hotel
in Clayton, Missouri, where he was
found to have in his possession cocaine,
as well as two prescription controlled
substances—a combination drug
containing hydrocodone, a schedule III
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
controlled substance, and alprazolam, a
schedule IV controlled substance. Id.
The Order further alleged that the
hydrocodone and the alprazolam ‘‘had
been dispensed in the name of an
acquaintance’’ of Respondent. Id.
Relatedly, the Show Cause Order
alleged that Respondent was
subsequently indicted in state court on
one felony count of possession of
cocaine, and two felony counts of
obtaining controlled substances by
fraud. Id. The Order further alleged that
on January 31, 2003, Respondent pled
guilty to all three counts, but that he
was allowed to withdraw his pleas after
he completed a ‘‘one-year drug
program.’’ 1 Id. at 1–2.
Respondent, through his counsel,
requested a hearing on the allegations.
ALJ Ex. 2. The matter was assigned to
Administrative Law Judge (ALJ) Gail
Randall, who conducted a hearing in St.
Louis, Missouri, on May 15 and 16,
2007. At the hearing, both the
Government and Respondent put on
testimony and introduced documentary
evidence into the record. Following the
hearing, both parties submitted briefs
containing their proposed findings of
fact, conclusions of law, and argument.
On February 13, 2008, the ALJ issued
her recommended decision (ALJ). In her
decision, the ALJ concluded that the
1 The Order also noted that on March 10, 2003,
Respondent had surrendered his DEA registration,
that in February 2004, the Missouri State Board for
the Healing Arts had entered into a settlement
agreement with Respondent under which his
medical license was placed on probation for seven
years, and that in April 2006, Respondent’s state
controlled substances registration had been
restored. Id. at 1–2.
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 74, Number 44 (Monday, March 9, 2009)]
[Notices]
[Pages 10076-10077]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-4945]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated November 26, 2008, and published in the Federal
Register on December 5, 2008, (73 FR 74194), Cerilliant Corporation,
811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as an importer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)............................ I
Methcathinone (1237)........................ I
N-Ethylamphetamine (1475)................... I
N,N-Dimethylamphetamine (1480).............. I
Fenethylline (1503)......................... I
Gamma hydroxybutyric acid (2010)............ I
Ibogaine (7260)............................. I
Lysergic acid diethylamide (7315)........... I
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine(7348).
Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
3,4,5-Trimethoxyamphetamine (7390).......... I
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395).... I
2,5-Dimethoxyamphetamine (7396)............. I
3,4-Methylenedioxyamphetamine (7400)........ I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405).... I
4-Methoxyamphetamine (7411)................. I
Alpha-methyltryptamine (7432)............... I
Diethyltryptamine (7434).................... I
Dimethyltryptamine (7435)................... I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
N-Benzylpiperazine (7493)................... I
Etorphine (except HCl) (9056)............... I
Heroin (9200)............................... I
Morphine-N-oxide (9307)..................... I
Normorphine (9313).......................... I
Pholcodine (9314)........................... I
Dextromoramide (9613)....................... I
Dipipanone (9622)........................... I
Trimeperidine (9646)........................ I
[[Page 10077]]
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Methylphenidate (1724)...................... II
Amobarbital (2125).......................... II
Pentobarbital (2270)........................ II
Secobarbital (2315)......................... II
Phencyclidine (7471)........................ II
Phenylacetone (8501)........................ II
Cocaine (9041).............................. II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Benzoylecgonine (9180)...................... II
Ethylmorphine (9190)........................ II
Meperidine (9230)........................... II
Methadone (9250)............................ II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................. II
Oripavine (9330)............................ II
Thebaine (9333)............................. II
Levo-alphacetylmethadol (9648).............. II
Oxymorphone (9652).......................... II
Fentanyl (9801)............................. II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the manufacture of analytical reference
standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Cerilliant Corporation to import the basic classes of
controlled substances is consistent with the public interest, and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Cerilliant Corporation to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic classes of controlled substances listed.
Dated: March 4, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-4945 Filed 3-6-09; 8:45 am]
BILLING CODE 4410-09-P
